Tag Archives: Gilead Sciences Inc.

Top Stories for Week of August 10, 2020

      No Comments on Top Stories for Week of August 10, 2020

Pfizer to help manufacture Gilead’s remdesivir for COVID-19. Pfizer Inc. (NYC) on Friday said it inked a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc. (Foster… Read more »

Top Stories for Week of July 27, 2020

California, Florida report record numbers of daily COVID-19 deaths; CDC says rates likely 10 times higher than reported. The US came just shy of breaking its single-day record for new… Read more »

Top Stories for Week of July 20, 2020

COVID-19 cases surge in US, elsewhere, with no end in sight; mask wearing, school openings still contentious. Divided Americans clashed anew over mask mandates and the reopening of schools on… Read more »

Top Stories for Week of May 18, 2020

COVID-19 cases slacken in US, but as more states reopen, the future is shaky. More than two-thirds of US states have lifted or relaxed restrictions on business and public life… Read more »

Top Stories for Week of May 11, 2020

Quarrel flares up between White House and the CDC over reopening guidelines. The Centers for Disease Control and Prevention has repeatedly found its suggestions for fighting the coronavirus outbreak taking… Read more »

Top Stories for Week of May 4, 2020

Trump’s Warp-Speed Plan aims to produce COVID-19 vaccine this year. US President Donald Trump said on Thursday (April 30, 2020) the US plans to accelerate the development of a coronavirus… Read more »

Top Stories for Week of April 20, 2020

Trump gives governors 3-step plan to revive economy soon; many experts doubt it will happen. The White House is encouraging states to begin opening back up and lifting social-distancing measures… Read more »

Top Stories for Week of March 9, 2020

      No Comments on Top Stories for Week of March 9, 2020

COVID-19 Addenda: Trump signs $8.3 billion emergency spending package; Italy coronavirus deaths near 200; $2 billion needed to develop new vaccine; U of Washington has closed classrooms. President Donald Trump… Read more »

Top Stories for Week of March 2, 2020

As the situation worsens, Gilead begins two, late-stage studies to test drug for coronavirus. The coronavirus, or COVID-19, has infected more than 80,000 people in about three dozen countries since… Read more »

Why Galapagos’s Phase 3 rheumatoid arthritis success is largely irrelevant.

The News: Galapagos NV (Mechelen BEL) and Gilead Sciences Inc. (Foster City CA) have reported positive results from a Phase 3 trial testing Galapagos’s lead drug candidate in patients with… Read more »